CD274 and melanoma: Finally, the outcome of melanoma and immune cell encounters depends on sufficient activation of the immune cells present in the tumor microenvironment, which melanoma cells prohibit by upregulating the expression of programmed death-ligand 1 (PD-L1) [168].